The latest content updates from the pharmaceutical-technology.com web site http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ http://www.pharmaceutical-technology.com/content/images/logo_big.gif http://www.pharmaceutical-technology.com/news/newsnew-cost-cutting-medicaid-rule-could-save-us-billions http://www.pharmaceutical-technology.com/news/newsnew-cost-cutting-medicaid-rule-could-save-us-billions A newly proposed cost-cutting rule implemented into the US Medicaid programme could save the country up to $17.7bn over five years, say US health officials. Fri, 03 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsmerck-receives-fda-approval-for-janumet http://www.pharmaceutical-technology.com/news/newsmerck-receives-fda-approval-for-janumet US-based pharmaceutical company Merck has received US Food and Drug Administration (FDA) approval for Janumet XR, its new type 2 diabetes treatment. Fri, 03 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/contractors/purification/scavenging-technologies2/ http://www.pharmaceutical-technology.com/contractors/purification/scavenging-technologies2/ Scavenging Technologies, a business unit of Johnson Matthey dedicated to product purification and recovery of precious and base metals, offers an extensive range of pure, fast and effective metal scavengers for use in the pharmaceutical industry. Thu, 02 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/contractors/excipients/evonik-pharma-polymers/ http://www.pharmaceutical-technology.com/contractors/excipients/evonik-pharma-polymers/ With its Pharma Polymers product line, Evonik is a major provider of functional pharmaceutical excipients and advanced formulation solutions. Thu, 02 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsgeneric-liptor-causes-pfizer-profit-slump http://www.pharmaceutical-technology.com/news/newsgeneric-liptor-causes-pfizer-profit-slump Pharmaceutical major Pfizer has announced a 50% slump in net income for Q4 2011 as the company suffers at the hands of generic versions of its cholesterol blockbuster Lipitor. Thu, 02 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/features/featureless-is-more-why-rare-disease-funding-is-on-the-up/ http://www.pharmaceutical-technology.com/features/featureless-is-more-why-rare-disease-funding-is-on-the-up/ Despite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National Organization for Rare Disorders (NORD) and Dr Steve Groft of the Off… Thu, 02 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsastrazeneca-job-cuts-more-severe-than-feared http://www.pharmaceutical-technology.com/news/newsastrazeneca-job-cuts-more-severe-than-feared Job cuts at Anglo-Swedish pharmaceutical firm AstraZeneca (AZ) are to be worse than feared, following an announcement made by the company amid rumours previously reported in the Sunday Times. Thu, 02 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/contractors/packaging/schott-packaging/pressschott-appoints-vice-president-of-global-syringe-business.html http://www.pharmaceutical-technology.com/contractors/packaging/schott-packaging/pressschott-appoints-vice-president-of-global-syringe-business.html SCHOTT has appointed Christophe Muguet as vice president of its global syringe business. He leads this area's business activities as part of SCHOTT Pharmaceutical Packaging from the offices in St Gallen, Switzerland. Wed, 01 Feb 2012 16:36:47 GMT http://www.pharmaceutical-technology.com/news/newsroches-skin-cancer-drug-erivedge-given-fda-nod http://www.pharmaceutical-technology.com/news/newsroches-skin-cancer-drug-erivedge-given-fda-nod Roche’s skin cancer drug Eviredge, developed in collaboration with Curis, has been approved by the US Food and Drug Administration. Wed, 01 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsrumoured-job-cuts-at-astrazeneca http://www.pharmaceutical-technology.com/news/newsrumoured-job-cuts-at-astrazeneca AstraZeneca is rumoured to be cutting up to 3,000 further jobs ahead of posting its full-year financial results, reports published in the Sunday Times suggest. Wed, 01 Feb 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newspakistan-supreme-court-orders-release-of-pharma-owners http://www.pharmaceutical-technology.com/news/newspakistan-supreme-court-orders-release-of-pharma-owners Pakistan’s Supreme Court has ordered the release of two owners of pharmaceutical companies as part of an investigation into deaths caused by the reaction from drugs distributed by the Punjab Institute of Cardiology. Tue, 31 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/features/featureahead-in-the-cloud-a-new-home-for-clinical-trial-data/ http://www.pharmaceutical-technology.com/features/featureahead-in-the-cloud-a-new-home-for-clinical-trial-data/ As the volume and complexity of clinical trial data grows, scientists need new ways to filter information. Elly Earls speaks to SAFE Bio-Pharma's Mollie Shields-Uehling and IBM's Chris Hines about why moving to the cloud could reduce clinical trial c… Tue, 31 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsfda-approves-amylins-diabetes-drug-bydureon http://www.pharmaceutical-technology.com/news/newsfda-approves-amylins-diabetes-drug-bydureon The US Food and Drug Administration (FDA) has approved Amylin’s once-weekly diabetes drug Bydureon at the third time of asking. Tue, 31 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/projects/2012-olympics-anti-doping-laboratory/ http://www.pharmaceutical-technology.com/projects/2012-olympics-anti-doping-laboratory/ The 2012 London Olympics will be the first Olympic event to have an anti-doping laboratory sponsored by a pharmaceutical company. Tue, 31 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/projects/gulf-pharmaceutical-industries-julphar-insulin-production-facility-uae/ http://www.pharmaceutical-technology.com/projects/gulf-pharmaceutical-industries-julphar-insulin-production-facility-uae/ Gulf Pharmaceutical Industries, known popularly as Julphar, is set to inaugurate the first ever insulin production facility in the Middle East. Mon, 30 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsbig-pharma-to-collaborate-to-combat-neglected-diseases http://www.pharmaceutical-technology.com/news/newsbig-pharma-to-collaborate-to-combat-neglected-diseases Some of the world’s largest pharmaceutical companies are joining forces with health organisations to donate drugs aimed at controlling or eradicating ten neglected tropical diseases by 2020. Mon, 30 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsamgen-to-acquire-micromet http://www.pharmaceutical-technology.com/news/newsamgen-to-acquire-micromet US-based pharmaceutical firm Amgen is to acquire the Germany-based biotechnology company Micromet in a deal that values the company at approximately $1.16bn. Mon, 30 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsxenoport-accuses-gsk-of-contract-breach http://www.pharmaceutical-technology.com/news/newsxenoport-accuses-gsk-of-contract-breach US-based Xenoport has accused UK-based pharmaceutical major GlaxoSmithKline (GSK) of a breach of contract and is threatening to end the pact relating to restless legs syndrome medication Horizant. Fri, 27 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/news/newsindian-agencies-seize-hospital-records-after-fake-drugs-cause-cardiac-patient-deaths http://www.pharmaceutical-technology.com/news/newsindian-agencies-seize-hospital-records-after-fake-drugs-cause-cardiac-patient-deaths Federal agencies in Pakistan are investigating the cause of over cardiac patient deaths linked to fake drugs administered to some 40,000 patients at a Government run hospital. Fri, 27 Jan 2012 00:00:00 GMT http://www.pharmaceutical-technology.com/projects/h3-biomedicine-new-research-facility/ http://www.pharmaceutical-technology.com/projects/h3-biomedicine-new-research-facility/ H3 Biomedicine, the American subsidiary of Tokyo-based company Eisai, opened its new research facility in Cambridge, in the state of Massachusetts, US, in December 2011. Thu, 26 Jan 2012 00:15:00 GMT